Low albumin and the albumin–globulin ratio (AGR) were associated with vascular adverse events. Our study explores the AGR as a predictor of mortality after non-ST-segment elevation myocardial infarction (NSTEMI). In an observational study of 570 NSTEMI patients admitted to a tertiary center between 2004 and 2006, patients were stratified into equal tertiles according to AGR. The primary outcome was 4-year all-cause mortality. The 4-year mortality rates in the first, second, and third AGR tertiles were 88 (47%) of 189, 48 (25%)of 190 , and 19 (10%) of 191, respectively (P < .0001). After adjusting for 20 confounding variables, AGR first tertile (AGR <1.12) had a higher mortality versus second tertile (hazard ratio [HR] 2.6, P < .001). Likewise, the AGR second tertile had higher mortality versus the third tertile (AGR ≥1.34; HR 2.3, P = .004). The albumin–globulin ratio is a significant independent predictor of long-term mortality after NSTEMI in patients with normal serum albumin levels. Further studies are needed to explain the underlying mechanisms.
McPhersonRichard“Chapter 19: Specific proteins”McPherson and Pincus: Henry’s clinical diagnosis and management by laboratory methods, 21st Ed. 2006. pp. 262–270.
2.
NelsonJJLiaoDSharrettAR. Serum albumin level as a predictor of incident coronary heart disease: the atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;151(5):468–477.
3.
DaneshJCollinsRApplebyPPetoR. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279(18):1477–1482.
4.
WeijenbergMPFeskensEJSouverijnJHKromhoutD. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology. 1997;8(1):87–92.
5.
GillumRFMakucDM. Serum albumin, coronary heart disease, and death. Am Heart J. 1992;123(2):507–513.
6.
CortiMCSaliveMEGuralnikJM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol. 1996;49(5):519–526.
7.
KullerLHEichnerJEOrchardTJGranditsGAMcCallumLTracyRP. The relation between serum albumin levels and risk of coronary heart disease in the multiple risk factor intervention trial. Am J Epidemiol. 1991;134(11):1266–1277.
8.
CortiMCGuralnikJMSaliveMESorkinJD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994;272(13):1036–1042.
9.
DjousséLRothmanKJCupplesLALevyDEllisonRC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham offspring study. Circulation. 2002;106(23):2919–2924.
10.
PhillipsAShaperAGWhincupPH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet. 1989;2(8677):1434–1436.
11.
GanotakisESVrentzosGEGaziIF. Fibrinogen, lipoprotein (a), albumin and bilirubin (F-L-A-B) levels and cardiovascular risk calculated using the Framingham equation. In Vivo. 2007;21(4):685–694.
12.
SimsFHGavinJBEdgarSKoelmeyerT. Diffusion of gamma globulin into the arterial wall identifies localized entry of lipid and cells in atherosclerosis. Coron Artery Dis. 2001;12(1):21–30.
13.
AllikmetsKParikTTeesaluR. Fibrinogen and the albumin-globulin ratio in essential hypertension: relations to plasma renin system activity. J Hum Hypertens. 1996;10(2):105–109.
14.
TanahashiNGotohFTomitaM. Enhanced erythrocyte aggregability in occlusive cerebrovascular disease. Stroke. 1989;20(9):1202–1207.
15.
BeamerNCoullBMSextonGde GarmoPKnoxRSeamanG. Fibrinogen and the albumin-globulin ratio in recurrent stroke. Stroke. 1993;24(8):1133–1139.
16.
AzabBZaherMWeiserbsKF. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470–476.
17.
GrangerCBGoldbergRJDabbousO. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345–2353.
18.
TangEWWongCKHerbisonP. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007;153(1):29–35.
19.
BhatiaRSGargRKGaurSP. Predictive value of routine hematological and biochemical parameters on 30-day fatality in acute stroke. Neurol India. 2004;52(2):220–223.
20.
LoweGD.Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost. 2005;3(8):1618–1627.
21.
MoshageHJJanssenJAFranssenJHHafkenscheidJCYapSH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest. 1987;79(6):1635–1641.
22.
KaysenGARathoreVShearerGCDepnerTA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995;48(2):510–516.
23.
AnavekarNSGansDJBerlT. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int. Suppl. 2004;66(92):S50–S55.
24.
LeeWSKimTY. Relation between red blood cell distribution width and inflammatory biomarkers in rheumatoid arthritis. Arch Pathol Lab Med. 2010;134(4):505–506.
25.
SembaRDPatelKVFerrucciL. Serum antioxidants and inflammation predict red cell distribution width in older women: the women's health and aging study I. Clin Nutr. 2010;29(5):600–604.
26.
GibsonPHCroalBLCuthbertsonBH. Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J. 2007;154(5):995–1002.
27.
DuffyBKGurmHSRajagopalVGuptaREllisSGBhattDL. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention. Am J Cardiol. 2006;97(7):993–996.
28.
NunezJNunezEBodiV. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747–752.
29.
TamhaneUUAnejaSMontgomeryDRogersEKEagleKAGurmHS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6):653–657.
30.
TonelliMSacksFArnoldMMoyeLDavisBPfefferM. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2):163–168.
31.
AniCOvbiageleB. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277(1-2):103–108.
32.
PoludasuSMarmurJDWeedonJKhanWCavusogluE. Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost. 2009;102(3):581–587.
33.
DabbahSHammermanHMarkiewiczWAronsonD. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010;105(3):312–317.
34.
WalshPNMillsDCWhiteJG. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol. 1977;36(2):287–296.
35.
MikhailidisDPMikhailidisAMDandonaP. Effect of human plasma proteins on stabilisation of platelet anti-aggregatory activity of prostacyclin. Ann Clin Biochem. 1982;19(pt 4):241–244.
36.
IshikawaYSasakawaSTakaseMOsadaY. Effect of albumin immobilization by plasma polymerization on platelet reactivity. Thromb Res. 1984;35(2):193–202.
37.
RaoAKKoikeKDayHJSmithJBHolmsenH. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets. Am J Clin Pathol. 1985;83(6):687–696.
38.
PorcellatiSGreselePStasiM. Original article: albumin prevents TxB, formation from thrombin-stimulated human platelets by sequestering the liberated arachidonic acid in the extracellular space. Platelets. 1995;6(6):381–387.
39.
GreselePDeckmynHHuybrechtsEVermylenJ. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol. 1984;33(13):2083–2088.
40.
GreenRARussoEAGreeneRTKabelAL. Hypoalbuminemia-related platelet hypersensitivity in two dogs with nephrotic syndrome. J Am Vet Med Assoc. 1985;186(5):485–488.
41.
SloandEMBernMMKaldanyA. Effect on platelet function of hypoalbuminemia in peritoneal dialysis. Thromb Res. 1986;44(4):419–425.
42.
MikhailidisDPGanotakisES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7(3):125–137.
43.
BernlochnerISteinhublSBraunS. Association between inflammatory biomarkers and platelet aggregation in patients under chronicclopidogrel treatment. Thromb Haemost. 2010;104(6):1193–1200.
44.
PeerschkeEIYinWGhebrehiwetB. Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol. 2010;47(13):2170–2175.
